Maura L Furey

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory
    Maura L Furey
    Mood and Anxiety Disorders Program, NIMH, NIH, Bethesda, MD 20892, USA
    J Cogn Neurosci 20:1342-53. 2008
  2. pmc Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    JAMA Psychiatry 70:280-90. 2013
  3. pmc Baseline mood-state measures as predictors of antidepressant response to scopolamine
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, NIMH, NIH, Bethesda, MD 20892, USA
    Psychiatry Res 196:62-7. 2012
  4. pmc Scopolamine produces larger antidepressant and antianxiety effects in women than in men
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA
    Neuropsychopharmacology 35:2479-88. 2010
  5. pmc Dissociation of face-selective cortical responses by attention
    Maura L Furey
    Laboratory of Brain and Cognition and Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 103:1065-70. 2006
  6. pmc Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 63:1121-9. 2006
  7. pmc Selective effects of cholinergic modulation on task performance during selective attention
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Neuropsychopharmacology 33:913-23. 2008
  8. pmc The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder
    Teresa A Victor
    National Institutes of Health, National Institute of Mental Health, Bethesda, Maryland, USA
    PLoS ONE 7:e46439. 2012
  9. pmc Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls
    Arlener D Turner
    National Institutes of Mental Health Experimental and Pathophysiology Branch, NIMH, CRC, Bethesda, MD 20892, USA
    Neuropsychologia 50:2348-55. 2012
  10. pmc Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder
    Teresa A Victor
    National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
    Arch Gen Psychiatry 67:1128-38. 2010

Detail Information

Publications19

  1. pmc Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory
    Maura L Furey
    Mood and Anxiety Disorders Program, NIMH, NIH, Bethesda, MD 20892, USA
    J Cogn Neurosci 20:1342-53. 2008
    ....
  2. pmc Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    JAMA Psychiatry 70:280-90. 2013
    ..Scopolamine produces rapid antidepressant effects and thus offers the opportunity to characterize potential biomarkers of treatment response within short periods...
  3. pmc Baseline mood-state measures as predictors of antidepressant response to scopolamine
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, NIMH, NIH, Bethesda, MD 20892, USA
    Psychiatry Res 196:62-7. 2012
    ..These results indicate that self-report mood-ratings obtained before treatment can predict response outcome to scopolamine, and suggest that a constellation of mood-state features may be related to clinical response...
  4. pmc Scopolamine produces larger antidepressant and antianxiety effects in women than in men
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA
    Neuropsychopharmacology 35:2479-88. 2010
    ..6, p=0.001) showed that the antianxiety response was greater in women. Men and women show a rapid antidepressant response following scopolamine, but the magnitude of response is larger in women than in men...
  5. pmc Dissociation of face-selective cortical responses by attention
    Maura L Furey
    Laboratory of Brain and Cognition and Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 103:1065-70. 2006
    ..By contrast, the early, face-specific M170 that was not modulated by attention likely reflects a rapid, feed-forward phase of face-selective processing...
  6. pmc Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 63:1121-9. 2006
    ..002). Subsequently a clinical trial was designed to assess more specifically the antidepressant efficacy of scopolamine...
  7. pmc Selective effects of cholinergic modulation on task performance during selective attention
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Neuropsychopharmacology 33:913-23. 2008
    ..The findings are discussed within the context of the role of acetylcholine both in stimulus processing and stimulus salience, and in establishing attention biases through top-down and bottom-up mechanisms of attention...
  8. pmc The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder
    Teresa A Victor
    National Institutes of Health, National Institute of Mental Health, Bethesda, Maryland, USA
    PLoS ONE 7:e46439. 2012
    ..The extended functional anatomical network that maintains this response bias has not been established, however...
  9. pmc Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls
    Arlener D Turner
    National Institutes of Mental Health Experimental and Pathophysiology Branch, NIMH, CRC, Bethesda, MD 20892, USA
    Neuropsychologia 50:2348-55. 2012
    ..This suggests that larger hippocampal volume is related to better memory recall in depression, but specifically with regard to utilizing an inferior memory strategy...
  10. pmc Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder
    Teresa A Victor
    National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
    Arch Gen Psychiatry 67:1128-38. 2010
    ..However, few studies have investigated such biases toward implicitly presented stimuli...
  11. pmc Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial
    Wayne C Drevets
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Psychiatry 67:432-8. 2010
    ..The present study aimed to replicate this finding in an independent sample limited to unipolar depressives...
  12. ncbi request reprint Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy
    Vicente Ibanez
    Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
    Brain Res Bull 63:147-54. 2004
    ..Thus, statistically significant age reductions in regional brain glucose metabolism, corrected for brain atrophy, are not detectable in healthy normotensive men scanned while in the resting state...
  13. pmc Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
    Wayne C Drevets
    Section on Neuroimaging in Mood and Anxiety Disorders, National Institute of Mental Health, National Institutes of Health NIH NIMH DIRP, 15K North Dr, Room 210, Bethesda, MD 20892, USA
    Brain Struct Funct 213:93-118. 2008
    ..This paper discusses these systems together with the neurochemical systems that impinge on them and form the basis for most pharmacological therapies...
  14. pmc The prominent role of stimulus processing: cholinergic function and dysfunction in cognition
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin Neurol 24:364-70. 2011
    ....
  15. pmc Human biomarkers of rapid antidepressant effects
    Carlos A Zarate
    Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Biol Psychiatry 73:1142-55. 2013
    ..g., ketamine or scopolamine). This alternative translational model for new treatments in psychiatry would facilitate shorter studies, improve feasibility, and increase higher compound throughput testing for these devastating disorders...
  16. doi request reprint In vivo evaluation of the effect of stimulus distribution on FIR statistical efficiency in event-related fMRI
    J Martijn Jansma
    Mood and Anxiety Disorders Program, Molecular Imaging Branch, Section on Neuroimaging in Mood and Anxiety Disorders, NIMH, NIH, United States
    J Neurosci Methods 215:190-5. 2013
    ..Our in vivo measurements can be used to aid in making an informed decision between freedom in protocol design and statistical efficiency...
  17. pmc Neural basis of abnormal response to negative feedback in unmedicated mood disorders
    Joana V Taylor Tavares
    Department of Psychiatry, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK
    Neuroimage 42:1118-26. 2008
    ..Disrupted top-down control by the prefrontal cortex of the amygdala may underlie this abnormal response to negative feedback in unipolar depression...
  18. ncbi request reprint Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine
    Ulderico Freo
    Laboratory of Clinical Biochemistry, Medical School, University of Pisa, Via Roma, 55, I 56126 Pisa, Italy
    Am J Psychiatry 162:2061-70. 2005
    ..The current study was designed to determine how healthy aging influences the neural response to working memory before and during pharmacological potentiation of the cholinergic system...
  19. pmc Beyond sensory images: Object-based representation in the human ventral pathway
    Pietro Pietrini
    Laboratory of Clinical Biochemistry, Department of Experimental Pathology, University of Pisa Medical School, I 56126 Pisa, Italy
    Proc Natl Acad Sci U S A 101:5658-63. 2004
    ..These results demonstrate that the representation of objects in the ventral visual pathway is not simply a representation of visual images but, rather, is a representation of more abstract features of object form...